Back
Canaan Vs. Lyra Therapeutics Industry Stock Comparison
Buy
59
CAN
Canaan
Last Price:
$0.80
Seasonality Move:
-7.84%
Sell
15
LYRA
Lyra Therapeutics
Last Price:
$7.99
Seasonality Move:
-2.43%
Sell
15
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $7.95. The Score for LYRA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CAN Stock Price Chart
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $7.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.
CAN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 51.58 | Buy |
Chaikin Money Flow: | -14700602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.86) | Buy |
Bollinger Bands (100): | (0.62 - 0.96) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 41.08 | Sell |
Chaikin Money Flow: | -13117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.86 - 10.86) | Sell |
Bollinger Bands (100): | (3.86 - 12.9) | Sell |
CAN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.87 | Sell |
20-day SMA: | 0.78 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 0.84 | Sell |
20-day EMA: | 0.8 | Buy |
50-day EMA: | 0.77 | Buy |
200-day EMA: | 1.09 | Sell |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.23 | Sell |
20-day SMA: | 8.68 | Sell |
50-day SMA: | 10.34 | Sell |
200-day SMA: | 9.43 | Sell |
8-day EMA: | 1.77 | Buy |
20-day EMA: | 0.76 | Buy |
50-day EMA: | 0.31 | Buy |
200-day EMA: | 0.08 | Buy |
Canaan Earnings Growth & CAN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.22 per share, an increase this year of $0.08 per share, and an increase next year of $0.43 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Canaan Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |